YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer

Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We es...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Izumi Suzuki, Sachiko Yoshida, Kouichi Tabu, Soshi Kusunoki, Yumiko Matsumura, Hiroto Izumi, Kazuo Asanoma, Hiroshi Yagi, Ichiro Onoyama, Kenzo Sonoda, Kimitoshi Kohno, Tetsuya Taga, Atsuo Itakura, Satoru Takeda, Kiyoko Kato
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2393a0674b334285888ea55f9ddad4b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2393a0674b334285888ea55f9ddad4b0
record_format dspace
spelling oai:doaj.org-article:2393a0674b334285888ea55f9ddad4b02021-12-02T12:11:45ZYBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer10.1038/s41598-021-83200-52045-2322https://doaj.org/article/2393a0674b334285888ea55f9ddad4b02021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83200-5https://doaj.org/toc/2045-2322Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We established a human YBX2-expressing Ishikawa (IK) cell line (IK-YBX2 cells). We analyzed gene expression associated with stemness and isolated SP cells from IK-YBX2 cells. The SP population of IK-YBX2 cells, the expression of ALDH1 and serial sphere-forming capacity were associated with levels of YBX2 expression. IK-YBX2 cells were resistant to anti-cancer drugs. In gene expression analysis, a gene for cancer testis antigen, CT45, was generally overexpressed in IK-YBX2 cells. YBX2-mediated CT45 expression was associated with increased levels of self-renewal capacity and paclitaxel resistance. The level of CT45 expression was enhanced in high-grade and/or advanced stages of human endometrial cancer tissues. We conclude that expression of YBX2 is essential for the stem cell-like phenotype. CT45 contributes to stemness associated with YBX2 and might be related to the progression of endometrial cancer.Izumi SuzukiSachiko YoshidaKouichi TabuSoshi KusunokiYumiko MatsumuraHiroto IzumiKazuo AsanomaHiroshi YagiIchiro OnoyamaKenzo SonodaKimitoshi KohnoTetsuya TagaAtsuo ItakuraSatoru TakedaKiyoko KatoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Izumi Suzuki
Sachiko Yoshida
Kouichi Tabu
Soshi Kusunoki
Yumiko Matsumura
Hiroto Izumi
Kazuo Asanoma
Hiroshi Yagi
Ichiro Onoyama
Kenzo Sonoda
Kimitoshi Kohno
Tetsuya Taga
Atsuo Itakura
Satoru Takeda
Kiyoko Kato
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
description Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We established a human YBX2-expressing Ishikawa (IK) cell line (IK-YBX2 cells). We analyzed gene expression associated with stemness and isolated SP cells from IK-YBX2 cells. The SP population of IK-YBX2 cells, the expression of ALDH1 and serial sphere-forming capacity were associated with levels of YBX2 expression. IK-YBX2 cells were resistant to anti-cancer drugs. In gene expression analysis, a gene for cancer testis antigen, CT45, was generally overexpressed in IK-YBX2 cells. YBX2-mediated CT45 expression was associated with increased levels of self-renewal capacity and paclitaxel resistance. The level of CT45 expression was enhanced in high-grade and/or advanced stages of human endometrial cancer tissues. We conclude that expression of YBX2 is essential for the stem cell-like phenotype. CT45 contributes to stemness associated with YBX2 and might be related to the progression of endometrial cancer.
format article
author Izumi Suzuki
Sachiko Yoshida
Kouichi Tabu
Soshi Kusunoki
Yumiko Matsumura
Hiroto Izumi
Kazuo Asanoma
Hiroshi Yagi
Ichiro Onoyama
Kenzo Sonoda
Kimitoshi Kohno
Tetsuya Taga
Atsuo Itakura
Satoru Takeda
Kiyoko Kato
author_facet Izumi Suzuki
Sachiko Yoshida
Kouichi Tabu
Soshi Kusunoki
Yumiko Matsumura
Hiroto Izumi
Kazuo Asanoma
Hiroshi Yagi
Ichiro Onoyama
Kenzo Sonoda
Kimitoshi Kohno
Tetsuya Taga
Atsuo Itakura
Satoru Takeda
Kiyoko Kato
author_sort Izumi Suzuki
title YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
title_short YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
title_full YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
title_fullStr YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
title_full_unstemmed YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
title_sort ybx2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2393a0674b334285888ea55f9ddad4b0
work_keys_str_mv AT izumisuzuki ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT sachikoyoshida ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT kouichitabu ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT soshikusunoki ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT yumikomatsumura ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT hirotoizumi ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT kazuoasanoma ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT hiroshiyagi ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT ichiroonoyama ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT kenzosonoda ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT kimitoshikohno ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT tetsuyataga ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT atsuoitakura ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT satorutakeda ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
AT kiyokokato ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer
_version_ 1718394560699170816